Adherence to Oral Hypoglycemic Agents in Hawaii

Introduction Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypogly...

Full description

Bibliographic Details
Main Authors: Deborah A. Taira, ScD, Rachel Lee
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2005-03-01
Series:Preventing Chronic Disease
Subjects:
Online Access:http://www.cdc.gov/pcd/issues/2005/apr/04_0049.htm
_version_ 1827801952631652352
author Deborah A. Taira, ScD
Rachel Lee
author_facet Deborah A. Taira, ScD
Rachel Lee
author_sort Deborah A. Taira, ScD
collection DOAJ
description Introduction Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypoglycemic agents. Methods This retrospective administrative data analysis included prescription refill claims for oral hypoglycemic agents from January 1, 1999, through June 30, 2003 (n = 20,685). Multivariate logistic regression analysis was used to examine the relationship between adherence and patient characteristics. Results Adherence was found to be strongly associated with age and ethnicity. Relative to the age subset 55 to 64 years, adherence increased as age increased, reaching a peak at age 74 (odds ratio [OR] 1.1; 95% confidence interval [CI], 1.01.20). Past the age of 85, adherence declined (OR 0.90; 95% CI, 0.820.98). Relative to white patients, the odds ratio of adherence was highest for Japanese patients (OR 1.20; 95% CI, 1.01.30) and lowest for Filipino patients (OR 0.78; 95% CI, 0.680.90). Gender was not associated with adherence. Conclusion Differences in adherence to oral hypoglycemic agents were found to be related to ethnicity and age. Adherence was found to be lowest in younger patients and Filipino patients. This is a significant finding considering that younger diabetic patients have been shown to have the poorest glycemic control and worst health outcomes. Although the literature on adherence to oral hypoglycemic agents and health outcomes in Filipino patients is limited, studies support an increased risk for developing diabetes in this group. This information can be used to target younger patients and Filipino patients to improve their adherence to oral hypoglycemic agents.
first_indexed 2024-03-11T20:31:53Z
format Article
id doaj.art-ffb1df35d68f4a88a12fd218dfb728a7
institution Directory Open Access Journal
issn 1545-1151
language English
last_indexed 2024-03-11T20:31:53Z
publishDate 2005-03-01
publisher Centers for Disease Control and Prevention
record_format Article
series Preventing Chronic Disease
spelling doaj.art-ffb1df35d68f4a88a12fd218dfb728a72023-10-02T08:34:47ZengCenters for Disease Control and PreventionPreventing Chronic Disease1545-11512005-03-0122Adherence to Oral Hypoglycemic Agents in HawaiiDeborah A. Taira, ScDRachel LeeIntroduction Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypoglycemic agents. Methods This retrospective administrative data analysis included prescription refill claims for oral hypoglycemic agents from January 1, 1999, through June 30, 2003 (n = 20,685). Multivariate logistic regression analysis was used to examine the relationship between adherence and patient characteristics. Results Adherence was found to be strongly associated with age and ethnicity. Relative to the age subset 55 to 64 years, adherence increased as age increased, reaching a peak at age 74 (odds ratio [OR] 1.1; 95% confidence interval [CI], 1.01.20). Past the age of 85, adherence declined (OR 0.90; 95% CI, 0.820.98). Relative to white patients, the odds ratio of adherence was highest for Japanese patients (OR 1.20; 95% CI, 1.01.30) and lowest for Filipino patients (OR 0.78; 95% CI, 0.680.90). Gender was not associated with adherence. Conclusion Differences in adherence to oral hypoglycemic agents were found to be related to ethnicity and age. Adherence was found to be lowest in younger patients and Filipino patients. This is a significant finding considering that younger diabetic patients have been shown to have the poorest glycemic control and worst health outcomes. Although the literature on adherence to oral hypoglycemic agents and health outcomes in Filipino patients is limited, studies support an increased risk for developing diabetes in this group. This information can be used to target younger patients and Filipino patients to improve their adherence to oral hypoglycemic agents.http://www.cdc.gov/pcd/issues/2005/apr/04_0049.htmgenomicspublic healthchronic disease preventionoral hypoglycemic agentsdental healthHawaii
spellingShingle Deborah A. Taira, ScD
Rachel Lee
Adherence to Oral Hypoglycemic Agents in Hawaii
Preventing Chronic Disease
genomics
public health
chronic disease prevention
oral hypoglycemic agents
dental health
Hawaii
title Adherence to Oral Hypoglycemic Agents in Hawaii
title_full Adherence to Oral Hypoglycemic Agents in Hawaii
title_fullStr Adherence to Oral Hypoglycemic Agents in Hawaii
title_full_unstemmed Adherence to Oral Hypoglycemic Agents in Hawaii
title_short Adherence to Oral Hypoglycemic Agents in Hawaii
title_sort adherence to oral hypoglycemic agents in hawaii
topic genomics
public health
chronic disease prevention
oral hypoglycemic agents
dental health
Hawaii
url http://www.cdc.gov/pcd/issues/2005/apr/04_0049.htm
work_keys_str_mv AT deborahatairascd adherencetooralhypoglycemicagentsinhawaii
AT rachellee adherencetooralhypoglycemicagentsinhawaii